Subtype

Breast Carcinoma by Gene Expression Profile

536 active trials6 approved drugs101 evidence items

NCIt: C53553

Clinical trials

Registered studies

1,297 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 536
Recruiting: 295
Ph III recruiting: 36
Growth YoY: +3.8%
Industry share: 29%
Top sponsor: Fudan University
Termination share: 45.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (216)

No study matches these filters